A Case of Pseudomonas Aeruginosa Endophthalmitis Treated with Intravitreal Ceftazidime Injection.
- Author:
Jun Soon KIM
1
;
Hyoung Bok PARK
Author Information
1. Department of Ophthalmology, School of Medicine Soonchunhyang University, Chunan, Korea.
- Publication Type:Original Article
- Keywords:
bacterial endophthalmitis;
intravitreal ceftazidime injection;
Pseudomonas aeruginosa endophthalmitis
- MeSH:
Amikacin;
Anti-Bacterial Agents;
Ceftazidime*;
Decision Making;
Diagnosis;
Emergencies;
Endophthalmitis*;
Intravitreal Injections;
Pseudomonas aeruginosa*;
Pseudomonas*;
Vancomycin
- From:Journal of the Korean Ophthalmological Society
1997;38(8):1464-1469
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Bacterial endophthalmitis is an ocular emergency that requires rapid diagnosis and therapeutic decision making. Before the use of intravitreal antibiotics, endophthalmitis almost always resulted in the loss of vision in the affected eye. The introduction of intravitreal injection of antibiotics had been a major advancement because it has resulted in a marked improvement in visual outcome. Current therapy is to administer broad-spectrum antibiotic agents covering both gram-positive and gram-negative organisms. Typically, vancomycin hydrochloride and aminoglycoside, such as amikacin sulfate, are administered as separate intrvitreal injections on an empiric basis. We experienced a case of culture-proven Pseudomonas aeruginosa endophthalmitis treated with intravitreal ceftazidime injection. We present it with a review of literature.
